期刊文献+

秀丽隐杆线虫-产碳青霉烯酶阴沟肠杆菌感染模型的建立及应用 被引量:2

Establishment and application of Caenorhabditis elegans-producing carbapenemase Enterobacter cloacae infection model
下载PDF
导出
摘要 目的建立秀丽隐杆线虫-产碳青霉烯酶阴沟肠杆菌感染模型,并利用该模型筛选体内有效治疗阴沟肠杆菌感染的药物。方法将产碳青霉烯酶的阴沟肠杆菌与线虫共培养,建立线虫-产碳青霉烯酶阴沟肠杆菌感染模型,选用7种临床常见的抗菌药物(米诺环素、多西环素、庆大霉素、氨曲南、亚胺培南、替加环素和多黏菌素B)对感染后的线虫进行治疗,观察并记录线虫的生存状态,根据线虫的存活率评价不同药物的疗效。结果产碳青霉烯酶的阴沟肠杆菌能够感染线虫并致其死亡,通过荧光探针标记可见细菌在线虫肠道内定植生长。使用多黏菌素B、替加环素、米诺环素、多西环素治疗后,线虫的生存率与对照组相比显著提高。结论成功建立了秀丽隐杆线虫-产碳青霉烯酶阴沟肠杆菌感染模型,并将该模型用于体内抗菌药物活性的筛选。 Objective To establish a model of Enterobacter cloacae and carbapenem-producing Enterobacter cloacae infection and to use this model to screen effective drugs for the treatment of Enterobacter cloacae infections. Methods Carbapenemase-producing Enterobacter cloacae was used to co-culture with nematode to establish an infection model of Caenorhabditis elegans-carbapenemase-producing Enterobacter cloacae. Seven common antibacterial drugs (minocycline, gentamicin, aztreonam, imipenem, tigecycline, and polymyxin B) were used to treat the infected nematodes. The survival status of nematodes was observed and recorded. The efficacy of different drugs based on the survival rate of nematodes was evaluated. Results High concentrations of carbapenem-producing Enterobacter cloacae can infect nematodes and cause their death. Fluorescent probes showed that bacteria could grow colonies in the gut. The nematode survival rate in the treatment group with the use of polymyxin B, tigecycline, minocycline, and doxycycline was significantly improved compared with the control group. Conclusion The infection model of Caenorhabditis elegan-carbapenemase-producing Enterobacter cloacae was established, and can be used for in vivo screening of antimicrobial activity.
作者 曹玲 陈丽丹 肖斌 王丽志 黄晓燕 李林海 Cao Ling;Chen Li-dan;Xiao Bin;Wang Li-zhi;Huang Xiao-yan;Li lin-hai(Department of Laboratory Medicine, Guangzhou General Hospital of Guangzhou Military Command of PLA, Guangzhou 510010;Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405)
出处 《中国抗生素杂志》 CAS CSCD 2018年第4期444-449,共6页 Chinese Journal of Antibiotics
关键词 碳青霉烯酶 阴沟肠杆菌 秀丽隐杆线虫 抗菌药物 Carbapenemase Enterobacter cloacae Caenorhabditis elegans Antimicrobials
  • 相关文献

参考文献7

二级参考文献85

  • 1顾怡明,张杰,俞云松,周志慧,杜小玲.多重耐药阴沟肠杆菌流行状况及耐药机制的研究[J].中华医院感染学杂志,2004,14(12):1321-1324. 被引量:62
  • 2苏丹虹,阜超,袁锦屏.2005年临床常见细菌附药性监测分析.第八届全国抗菌约物临床约药理学术会议.北京,2006.
  • 3Moy T I, Ball A R, Anklesaria Z, et al. Identification of novel antimicrobials using a live-animal infection model[J]. Proc Natl Acad Sci USA, 2006, 103(27): 10414-10419.
  • 4Breger J, Fuchs B B, Aperis G, etal. AntifungaJ chemical compounds identified using a C. elegans pathogenicity assay[J]. PLoS Pathog, 2007, 3(2): 168-178.
  • 5Brenner S. The genetics of Caenorhabditis elegans[J]. Genetics, 1974, 77(1): 71-94.
  • 6Lewis J A, Fleming J T. Basic culture methods[J]. Methods' Cell Biol, 1995, 48: 3-29.
  • 7Beanan M J, Strome S, Characterization of a germ-line proliferation mutation in C. elegans[J]. Development, 1992, 116: 755-766.
  • 8Kim D H, Feinbaum R, Alloing G, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity[J]. Science, 2002, 297(5581): 623-626.
  • 9Tan M W, Mahajan-Miklos S, Ausubel F M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis[J]. Proc Natl Acad Sci USA, 1999, 96(2): 715-720.
  • 10Stiernagle T. Maintenance of C. elegans[J]. WormBook, 2006: 1-11.

共引文献150

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部